FLVCR1

protein-coding

FLVCR heme transporter 1, the group of Solute carrier family 49

Gene summary

This gene encodes a member of the major facilitator superfamily of transporter proteins. The encoded protein is a heme transporter that may play a critical role in erythropoiesis by protecting developing erythroid cells from heme toxicity. This gene may play a role in posterior column ataxia with retinitis pigmentosa and the hematological disorder Diamond-Blackfan syndrome. [provided by RefSeq, Jan 2011]

Previous symbols:
  • AXPC1

MANE transcript

NM_014053.4

Inheritance

AR

ClinVar variants

P:73U:252B:129

Top phenotype

Retinopathy-sensory neuropathy syndrome; Neurodevelopmental disorder with microcephaly, absent speech, and hypotonia

gnomAD constraint

pLI —, LoF o/e 0.38

Max pathogenic AF

—

Genomic locus

chr1:212,858,275-212,899,363

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~41.1 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

FLVCR1-related retinopathy with or without ataxiaSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0100449

Submitter: PanelApp Australia

posterior column ataxia-retinitis pigmentosa syndromeDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0012177

Submitter: Illumina

The FLVCR1 gene is located on chromosome 1 at 1q32.3 and encodes the FLVCR heme transporter 1 protein, a member of the major facilitator superfamily of transporter proteins which is specifically involved in the transmembrane transport of cytoplasmic heme. The protein plays a critical role in erythropoiesis by protecting the developing erythroid cells from heme toxicity. FLVCR1 was first reported in relation to autosomal recesssive posterior column ataxia-retinitis pigmentosa syndrome in 2010 (21070897: Rajadhyaksha et al. 2010). At least 11 unique variants (including missense and loss of function variants) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data and experimental evidence. Variants in this gene have been reported in at least seven probands in three publications (27923065: Chiabrando et al. 2016; 27353947: Tiwari et al. 2016; 30656474: Kuehlewein et al. 2019). Variants in this gene segregated with disease in two families. Clinical variability was noted with affected individuals presenting with either posterior column ataxia with retinitis pigmentosa (PCARP), non-syndromic retinitis pigmentosa, or hereditary sensory and autonomic neuropathy (HSAN). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. It is suggested that the underlying disease mechanism may be heme overload (27923065: Chiabrando et al. 2016). This gene-disease relationship is supported by expression studies and in vitro functional assays in patient and non-patient cells (21070897: Rajadhyaksha et al. 2010; 27923065: Chiabrando et al. 2016). In summary, FLVCR1 is definitively associated with autosomal recessive posterior column ataxia-retinitis pigmentosa syndrome.

posterior column ataxia-retinitis pigmentosa syndromeDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0012177

Submitter: G2P

FLVCR1-related retinopathy with or without ataxiaDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0100449

Submitter: ClinGen

FLVCR1 was first reported in relation to autosomal recessive FLVCR1-related retinopathy with or without ataxia (also known as posterior column ataxia-retinitis pigmentosa syndrome; PCARP) in 2010 (Rajadhyaksha et al., PMID: 21070897). This condition is characterized by childhood onset retinal dystrophy and progressive sensory ataxia. At least 321 variants (e.g. missense, in-frame indel, nonsense, frameshift, large deletion, complex rearrangement, etc) have been reported in humans (ClinVar database). Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. This curation includes 12 variants (missense, frameshift, nonsense, intronic) from 11 probands from 5 publications (Rajadhyaksha et al, 2010, PMID: 21070897; Ishiura et al, 2011, PMID: 21267618; Castori et al, 2017, PMID: 28766925; Kuehlewein et al, 2019, PMID 30656474; Grudzinska Pechhacker et al, 2020, PMID: 32822874) in addition to segregation data (Rajadhyaksha et al, 2010, PMID: 21070897). More data is available in the literature but the maximum score for genetic evidence (12 points) has been reached. Experimental evidence included qPCR expression data in mice (Rajadhyaksha et al, 2010, PMID: 21070897), functional studies in patient cells, and a homology model of the protein (Grudzinska Pechhacker et al, 2020, PMID: 32822874). In summary, FLVCR1 has a definitive relationship with FLVCR1-related retinopathy with or without ataxia. This classification was approved by the ClinGen Retina GCEP on August 5, 2021.

posterior column ataxia-retinitis pigmentosa syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0012177

Submitter: Labcorp Genetics (formerly Invitae)

posterior column ataxia-retinitis pigmentosa syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0012177

Submitter: Orphanet

Clinical Genomic Database (CGD)

Retinopathy-sensory neuropathy syndrome; Neurodevelopmental disorder with microcephaly, absent speech, and hypotoniaAR

Manifestation: Hematologic; Neurologic; Ophthalmologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 9409377; 9855554; 21070897; 21267618; 22279524; 22483575; 27923065; 32822874; 39306721Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to FLVCR1 variants in ClinVar

17 Conditions Cataloged
not providedTotal: 425
Inborn genetic diseasesTotal: 69
not specifiedTotal: 62
Posterior column ataxia-retinitis pigmentosa syndromeTotal: 59
FLVCR1-related disorderTotal: 43
FLVCR1-related disordersTotal: 23
Retinal dystrophyTotal: 10
Neurodevelopmental disorder with microcephaly, absent speech, and hypotoniaTotal: 9

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_014053.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
18
clinvar
122
clinvar
141
missense
6
clinvar
17
clinvar
228
clinvar
7
clinvar
258
nonsense
4
clinvar
9
clinvar
13
start loss
1
clinvar
2
clinvar
3
frameshift
14
clinvar
15
clinvar
4
clinvar
33
splice donor/acceptor (+/-2bp)
1
clinvar
3
clinvar
2
clinvar
6
Total26472521290454

Highest pathogenic variant AF is 0.00034900446

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 24 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_014053.4RefSeqNP_054772.110MANE Select
ENST00000366971.9EnsemblENSP00000355938.410MANE Select
ENST00000419102.1EnsemblENSP00000414680.19Standard
ENST00000867613.1EnsemblENSP00000537672.111Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
flvcr1Danio rerio

Structure: nucleate erythrocyte

Quality: decreased amount

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Transport of small molecules
  • Iron uptake and transport

Biological Process

  • blood vessel development
  • in utero embryonic development
  • mitochondrial transport
  • cellular iron ion homeostasis
  • multicellular organism development

Molecular Function

  • transporter activity
  • protein binding
  • heme transporter activity
  • heme binding

Cellular Component

  • mitochondrion
  • plasma membrane
  • integral component of plasma membrane
  • mitochondrial membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000366971
Coding exons
10
Length
41109
Individuals with no LoFs
125704
Homozygous LoFs
0
Heterozygous LoFs
44
Defined
125748
p
0.000175
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.8522432830.8580.00001303516
Missense (PolyPhen)5069.4360.72009880
Synonymous-0.1931191161.020.000005671181
Loss of Function2.77923.50.3830.00000108292

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000250.00025rare
Latino/Admixed American0.000200.00020rare
Ashkenazi Jewish0.0000990.000099rare
East Asian0.000110.00011rare
Finnish00.0absent
European (Non-Finnish)0.000200.00020rare
South Asian0.000200.00020rare
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Isoform 1: Heme transporter that exports cytoplasmic heme. It can also export coproporphyrin and protoporphyrin IX, which are both intermediate products in the heme biosynthetic pathway. Does not export bilirubin. Heme export depends on the presence of HPX and is required to maintain intracellular free heme balance, protecting cells from heme toxicity. Heme export provides protection from heme or ferrous iron toxicities in liver, brain, sensory neurons and during erythtopoiesis, a process in which heme synthesis intensifies. Causes susceptibility to FeLV-C in vitro. {ECO:0000269|PubMed:10400745, ECO:0000269|PubMed:15369674, ECO:0000269|PubMed:20610401, ECO:0000269|PubMed:27923065}.;
Disease
DISEASE: Posterior column ataxia with retinitis pigmentosa (PCARP) [MIM:609033]: A neurodegenerative syndrome beginning in infancy with areflexia and retinitis pigmentosa. Nyctalopia (night blindness) and peripheral visual field loss are usually evident during late childhood or teenage years, with subsequent progressive constriction of the visual fields and loss of central retinal function over time. A sensory ataxia caused by degeneration of the posterior columns of the spinal cord results in a loss of proprioceptive sensation that is clinically evident in the second decade of life and gradually progresses. Scoliosis, camptodactyly, achalasia, gastrointestinal dysmotility, and a sensory peripheral neuropathy are variable features of the disease. Affected individuals have no clinical or radiological evidence of cerebral or cerebellar involvement. {ECO:0000269|PubMed:21070897, ECO:0000269|PubMed:21267618}. Note=The disease is caused by mutations affecting the gene represented in this entry. Defective neuronal heme transmembrane export due to FLVCR1 mutations may abrogate the neuroprotective effects of neuroglobin and initiate an apoptotic cascade that results in the selective degeneration of photoreceptors in the neurosensory retina and sensory neurons in the posterior spinal cord.; DISEASE: Note=Defects in FLVCR1 are a cause of a sensory neuropathy resulting in pain insensitivity. Patients have decreased sensing of pain, temperature and touch. Self-injury, ulcers and amputations are commonly observed in affected individuals. {ECO:0000269|PubMed:27923065}.;

Recessive Scores

pRec
0.112

Intolerance Scores

LoFtool
0.465
RVIS EVS
0.02
RVIS percentile EVS
55.45

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
K
Indispensability pred.
E
Indispensability score
0.650

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.